Clinical Trial Update: Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating cannabidiol (CBD) for neuroprotection against oxaliplatin-induced peripheral neuropathy in cancer patients and is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Colorectal Cancer
• Oxaliplatin-induced Peripheral Neuropathy

Drugs mentioned

• Cannabidiol (CBD) (cannabidiol)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients, Metastatic Colorectal Cancer (CRC) | EARLY_Phase 1 | Status: RECRUITING